Myriad Genetics (MYGN) Addresses HIPAA Complaint; Believes it 'Acted Appropriately'

May 19, 2016 4:57 PM EDT Send to a Friend
Myriad Genetics, Inc. (Nasdaq: MYGN) announced a complaint was filed against the Company with the Department of Health and Human ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login